These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 24646401)

  • 21. Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB.
    Boileau I; Warsh JJ; Guttman M; Saint-Cyr JA; McCluskey T; Rusjan P; Houle S; Wilson AA; Meyer JH; Kish SJ
    Mov Disord; 2008 Sep; 23(12):1776-80. PubMed ID: 18661545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo serotonin transporter and 1A receptor binding potential and ecological momentary assessment (EMA) of stress in major depression and suicidal behavior.
    Bartlett EA; Zanderigo F; Stanley B; Choo TH; Galfalvy HC; Pantazatos SP; Sublette ME; Miller JM; Oquendo MA; Mann JJ
    Eur Neuropsychopharmacol; 2023 May; 70():1-13. PubMed ID: 36780841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin (5-HT) in the regulation of depression-related emotionality: insight from 5-HT transporter and tryptophan hydroxylase-2 knockout mouse models.
    Araragi N; Lesch KP
    Curr Drug Targets; 2013 May; 14(5):549-70. PubMed ID: 23547810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased Pretreatment Amygdalae Serotonin Transporter Binding in Unipolar Depression Remitters: A Prospective PET Study.
    Ananth MR; DeLorenzo C; Yang J; Mann JJ; Parsey RV
    J Nucl Med; 2018 Apr; 59(4):665-670. PubMed ID: 28935838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin transporter knockout and repeated social defeat stress: impact on neuronal morphology and plasticity in limbic brain areas.
    Nietzer SL; Bonn M; Jansen F; Heiming RS; Lewejohann L; Sachser N; Asan ES; Lesch KP; Schmitt AG
    Behav Brain Res; 2011 Jun; 220(1):42-54. PubMed ID: 21238500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
    Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study.
    Reimold M; Batra A; Knobel A; Smolka MN; Zimmer A; Mann K; Solbach C; Reischl G; Schwärzler F; Gründer G; Machulla HJ; Bares R; Heinz A
    Mol Psychiatry; 2008 Jun; 13(6):606-13, 557. PubMed ID: 18268503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantifying serotonin transporters by PET with [11C]-DASB before and after interferon-α treatment.
    Shapiro PA; Sloan RP; Deochand C; Franceschi AM; Delorenzo C; Mann JJ; Parsey RV
    Synapse; 2014 Nov; 68(11):548-55. PubMed ID: 25043294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CB1 cannabinoid receptor-mediated aggressive behavior.
    Rodriguez-Arias M; Navarrete F; Daza-Losada M; Navarro D; Aguilar MA; Berbel P; Miñarro J; Manzanares J
    Neuropharmacology; 2013 Dec; 75():172-80. PubMed ID: 23916480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered sleep homeostasis after restraint stress in 5-HTT knock-out male mice: a role for hypocretins.
    Rachalski A; Alexandre C; Bernard JF; Saurini F; Lesch KP; Hamon M; Adrien J; Fabre V
    J Neurosci; 2009 Dec; 29(49):15575-85. PubMed ID: 20007481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of reduced endogenous 5-HT on the in vivo binding of the serotonin transporter radioligand 11C-DASB in healthy humans.
    Talbot PS; Frankle WG; Hwang DR; Huang Y; Suckow RF; Slifstein M; Abi-Dargham A; Laruelle M
    Synapse; 2005 Mar; 55(3):164-75. PubMed ID: 15605360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adipocyte cannabinoid CB1 receptor deficiency alleviates high fat diet-induced memory deficit, depressive-like behavior, neuroinflammation and impairment in adult neurogenesis.
    Suárez J; Rivera P; Aparisi Rey A; Pérez-Martín M; Arrabal S; Rodríguez de Fonseca F; Ruiz de Azua I; Lutz B
    Psychoneuroendocrinology; 2019 Dec; 110():104418. PubMed ID: 31491589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The personality trait openness is related to cerebral 5-HTT levels.
    Kalbitzer J; Frokjaer VG; Erritzoe D; Svarer C; Cumming P; Nielsen FA; Hashemi SH; Baaré WF; Madsen J; Hasselbalch SG; Kringelbach ML; Mortensen EL; Knudsen GM
    Neuroimage; 2009 Apr; 45(2):280-5. PubMed ID: 19135154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased vulnerability to psychosocial stress in heterozygous serotonin transporter knockout mice.
    Bartolomucci A; Carola V; Pascucci T; Puglisi-Allegra S; Cabib S; Lesch KP; Parmigiani S; Palanza P; Gross C
    Dis Model Mech; 2010; 3(7-8):459-70. PubMed ID: 20371729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Vivo Evaluation of 11C-DASB for Quantitative SERT Imaging in Rats and Mice.
    Walker M; Ehrlichmann W; Stahlschmidt A; Pichler BJ; Fischer K
    J Nucl Med; 2016 Jan; 57(1):115-21. PubMed ID: 26514178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice.
    Steiner MA; Wanisch K; Monory K; Marsicano G; Borroni E; Bächli H; Holsboer F; Lutz B; Wotjak CT
    Pharmacogenomics J; 2008 Jun; 8(3):196-208. PubMed ID: 17684478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shared changes in gene expression in frontal cortex of four genetically modified mouse models of depression.
    Hoyle D; Juhasz G; Aso E; Chase D; del Rio J; Fabre V; Hamon M; Lanfumey L; Lesch KP; Maldonado R; Serra MA; Sharp T; Tordera R; Toro C; Deakin JF
    Eur Neuropsychopharmacol; 2011 Jan; 21(1):3-10. PubMed ID: 21030216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced availability of serotonin transporters in obsessive-compulsive disorder correlates with symptom severity - a [11C]DASB PET study.
    Reimold M; Smolka MN; Zimmer A; Batra A; Knobel A; Solbach C; Mundt A; Smoltczyk HU; Goldman D; Mann K; Reischl G; Machulla HJ; Bares R; Heinz A
    J Neural Transm (Vienna); 2007; 114(12):1603-9. PubMed ID: 17713719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre- and postsynaptic serotonergic differences in males with extreme levels of impulsive aggression without callous unemotional traits: a positron emission tomography study using (11)C-DASB and (11)C-MDL100907.
    Rylands AJ; Hinz R; Jones M; Holmes SE; Feldmann M; Brown G; McMahon AW; Talbot PS
    Biol Psychiatry; 2012 Dec; 72(12):1004-11. PubMed ID: 22835812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of increased endogenous serotonin on the in vivo binding of [11C]DASB to serotonin transporters in conscious monkey brain.
    Yamamoto S; Onoe H; Tsukada H; Watanabe Y
    Synapse; 2007 Sep; 61(9):724-31. PubMed ID: 17559093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.